ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
BHL gets license from Defence Research and Development Organisation (DRDO) to manufacture and market “2-Deoxy-D-Glucose” (2-DG), used in control & treatment of Covid-19. firstwordpharma
July 09, 2021Bajaj Healthcare Limited (BHL) a leading manufacturer of APIs, Intermediates and Formulations, has received a licence from DRDO to Manufacture and Market of “2-Deoxy-D-Glucose” (2-DG) as approved medication for the treatment of COVID-19 patients.
Pharma Sources Insight July 2025
